Public commentary in response to the vaccine advisory groups’ meeting with the US Food and Drug Administration over the Emergency Use Authorization (EUA) of the COVID-19 vaccine in children (5-11) displayed overwhelming opposition to the EUA and vaccine-risk misperceptions. (April 19, 2024)
COVID-19 pediatric vaccine authorization, FDA authority, and individual misperception of risk
Share:
